Literature DB >> 25944459

Neuropathological sequelae of Human Immunodeficiency Virus and apathy: A review of neuropsychological and neuroimaging studies.

Roger C McIntosh1, Monica Rosselli2, Lucina Q Uddin3, Michael Antoni3.   

Abstract

Apathy remains a common neuropsychiatric disturbance in the Human Immunodeficiency Virus (HIV-1) despite advances in anti-retroviral treatment (ART). The goal of the current review is to recapitulate findings relating apathy to the deleterious biobehavioral effects of HIV-1 in the post-ART era. Available literatures demonstrate that the emergence of apathy with other neurocognitive and neuropsychiatric symptoms may be attributed to neurotoxic effects of viral proliferation, e.g., aggregative effect of Tat and gp120 on apoptosis, transport and other enzymatic reactions amongst dopaminergic neurons and neuroglia. An assortment of neuroimaging modalities converge on the severity of apathy symptoms associated with the propensity of the virus to replicate within frontal-striatal brain circuits that facilitate emotional processing. Burgeoning research into functional brain connectivity also supports the effects of microvascular and neuro-inflammatory injury linked to aging with HIV-1 on the presentation of neuropsychiatric symptoms. Summarizing these findings, we review domains of HIV-associated neurocognitive and neuropsychiatric impairment linked to apathy in HIV. Taken together, these lines of research suggest that loss of affective, cognitive and behavioral inertia is commensurate with the neuropathology of HIV-1.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apathy; DTI; Functional connectivity; Human Immunodeficiency Virus; MRI; Neurocognitive impairment; Neuropsychiatric dysfunction

Mesh:

Substances:

Year:  2015        PMID: 25944459     DOI: 10.1016/j.neubiorev.2015.04.008

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  19 in total

1.  Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure.

Authors:  Adam R Denton; Srimal A Samaranayake; Kristin N Kirchner; Robert F Roscoe; Shane N Berger; Steven B Harrod; Charles F Mactutus; Parastoo Hashemi; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

2.  Vocal emotion processing deficits in HIV-infected individuals.

Authors:  A González-Baeza; J R Arribas; I Pérez-Valero; S Monge; C Bayón; P Martín; S Rubio; F Carvajal
Journal:  J Neurovirol       Date:  2016-12-09       Impact factor: 2.643

3.  Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.

Authors:  Sarah Tymchuk; Daniela Gomez; Noshin Koenig; M John Gill; Esther Fujiwara; Christopher Power
Journal:  Can J Psychiatry       Date:  2017-12-11       Impact factor: 4.356

Review 4.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

5.  Anterior Insula Activation During Cardiac Interoception Relates to Depressive Symptom Severity in HIV-Positive and HIV-Negative Postmenopausal Women.

Authors:  Roger C McIntosh; Judith D Lobo; Michael Reed; Jennifer C Britton
Journal:  Psychosom Med       Date:  2022-09-06       Impact factor: 3.864

Review 6.  Neurobehavioral Manifestations of Human Immunodeficiency Virus/AIDS: Diagnosis and Treatment.

Authors:  Elyse J Singer; April D Thames
Journal:  Neurol Clin       Date:  2016-02       Impact factor: 3.806

7.  Effort and neuropsychological performance in HIV-infected individuals on stable combination antiretroviral therapy.

Authors:  Robert Paul; Gina Rhee; Laurie M Baker; Florin Vaida; Sarah A Cooley; Beau M Ances
Journal:  J Neurovirol       Date:  2017-09-11       Impact factor: 2.643

Review 8.  HIV Infection and Neurocognitive Disorders in the Context of Chronic Drug Abuse: Evidence for Divergent Findings Dependent upon Prior Drug History.

Authors:  Jessica M Illenberger; Steven B Harrod; Charles F Mactutus; Kristen A McLaurin; Asha Kallianpur; Rosemarie M Booze
Journal:  J Neuroimmune Pharmacol       Date:  2020-06-12       Impact factor: 4.147

Review 9.  Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns.

Authors:  Ameer Abutaleb; Sarah Kattakuzhy; Shyam Kottilil; Erin O'Connor; Eleanor Wilson
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

10.  Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage.

Authors:  Adam R Denton; Charles F Mactutus; Almeera U Lateef; Steven B Harrod; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2021-05-18       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.